tag negotiations 
STAT
JANUARY 30, 2024
In response to concerns over multimillion-dollar price tags for new gene therapies for sickle cell disease, the U.S. government on Tuesday announced a long-awaited “access model” designed to blunt the cost that state Medicaid programs would pay for these curative treatments. million and $3.1
STAT
MARCH 10, 2023
By law, Medicare will have to take a medication’s efficacy and its research and development costs into account when it starts to negotiate drug prices — but recent research shows pharma companies ignore those factors when they pick prices for their products. But neither factor has much effect, the studies concluded.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
MARCH 10, 2023
Enjoy, and see you soon … By law, Medicare will have to take a medication’s efficacy and its research and development costs into account when it starts to negotiate drug prices — but recent research shows pharma companies ignore those factors when they pick prices for their products , STAT explains. Two But be safe.
The Checkup by Singlecare
DECEMBER 8, 2023
If there’s a drug you need to take, but you can’t swing the steep price tag, ask your pharmacist to check SingleCare’s prices. We negotiate directly with major pharmacies and supermarkets like CVS, Walgreens, and Walmart for up to 80% off prescription costs. These customers did just that to save big.
Pharmaceutical Technology
FEBRUARY 10, 2023
This is not the first treatment to come with a high price tag. Most finance-based agreements are discount schemes, including simple discounts, compulsory discounts on ex-factory prices, or other types of discount price negotiations.
pharmaphorum
NOVEMBER 19, 2021
The cost-effectiveness agency had turned down Evrysdi (risdiplam) in draft guidance published in June, saying it was too expensive, but after negotiations with Roche has reached a deal that will make the drug available to around 1,500 people in England. million price tag make it is the most expensive treatment ever approved for NHS funding.
Pharmaceutical Technology
MAY 1, 2023
Shunxi will also hold an option to negotiate rights to other CAR-T products, which include the licenced IP. CTH-004 is developed by genetically altering patient T cells for inserting a chimeric antigen receptor (CAR) to target a marker (TAG-72) on ovarian cancer cells and delete genes which are involved in T cell function suppression.
Expert insights. Personalized for you.
140 
Let's personalize your content